Raymond James analyst Lawrence Keusch reiterated an Outperform rating on Masimo Corp. (NASDAQ: MASI) after the company announced the FDA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE